Automated Cell Culture System Market Trends

  • Report ID: 4262
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Automated Cell Culture System Market Trends

Growth Drivers

  • Significant Demand in the Treatment of Skin Problems - In 2022, over 6 million Americans were found to be living with psoriasis while about 200 million were across the globe.

The cell culture system puts regenerative medicines in use for patients practically. Cells are used by regenerative medicines in the form of therapeutic agents which are required for the medical treatment associated with repairing, rebuilding, and making the human body function properly. Hence such a significant utilization is estimated to propel the market growth over the forecast period.

  • Rising Cases of Non-Communicable Diseases - Data published by the World Health Organization showed that nearly 41 million individuals die due to non-communicable diseases every year.
  • Higher Prevalence of Infectious Diseases  - The annual rate of death caused by infectious diseases is estimated to be more than 15 million a year.
  • Growing Healthcare Expenditure Across the Globe - As per the statistics provided by the World Bank, global health expenditure was estimated to reach USD 1,121.9 per capita.
  • Increasing Number of Clinical Trials  - As of 2021, the number of clinical trials is estimated to be nearly 0.4 million in about 200 countries.

Challenges

  • Lack of Skilled Medical Professionals
  • Lack of Required Technology to Develop the Cell Culture System
  • Requirement for Higher Initial Investment

Automated Cell Culture System Market: Key Insights

Growth Drivers

  • Significant Demand in the Treatment of Skin Problems - In 2022, over 6 million Americans were found to be living with psoriasis while about 200 million were across the globe.

The cell culture system puts regenerative medicines in use for patients practically. Cells are used by regenerative medicines in the form of therapeutic agents which are required for the medical treatment associated with repairing, rebuilding, and making the human body function properly. Hence such a significant utilization is estimated to propel the market growth over the forecast period.

  • Rising Cases of Non-Communicable Diseases - Data published by the World Health Organization showed that nearly 41 million individuals die due to non-communicable diseases every year.

  • Higher Prevalence of Infectious Diseases  - The annual rate of death caused by infectious diseases is estimated to be more than 15 million a year.

  • Growing Healthcare Expenditure Across the Globe - As per the statistics provided by the World Bank, global health expenditure was estimated to reach USD 1,121.9 per capita.

  • Increasing Number of Clinical Trials  - As of 2021, the number of clinical trials is estimated to be nearly 0.4 million in about 200 countries.

Challenges

  • Lack of Skilled Medical Professionals
  • Lack of Required Technology to Develop the Cell Culture System
  • Requirement for Higher Initial Investment

The global automated cell culture system market is segmented and analyzed for demand and supply by end-user into academic institutes, biotech company, and research organization, out of which, the biotech company segment is projected to witness noteworthy growth over the forecast period. The growth of the segment can be accounted to the rising activities of research and development across the globe. For instance, the biotech industry was valued at approximately USD 450 billion in 2020.

On the other, on the basis of mode of delivery, automated cell culture system market is segmented into topical application, aerial diffusion, and direct inhalation. Out of all these, the topical application garnered the highest market share i.e. 41.03% in 2022. The rising technological advancements along with the huge investments made in the healthcare sector is expected to bring lucrative opportunities for the segment growth.

Base Year

2024

Forecast Year

2025-2037

CAGR

12.3%

Base Year Market Size (2024)

USD 8.21 billion

Forecast Year Market Size (2037)

USD 37.09 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4262
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of automated cell culture system is evaluated at USD 9.91 billion.

The automated cell culture system market size was valued at USD 8.21 billion in 2024 and is set to exceed USD 37.09 billion by 2037, expanding at over 12.3% CAGR during the forecast period i.e., between 2025-2037. Increasing stem cell research & development owing to the higher prevalence of related diseases will drive the market growth.

North America industry is predicted to dominate majority revenue share of 41% by 2037, attributed to rising investment in research and development in the region.

The major players in the market are Hitachi Power Solutions Co, Ltd., Lonza Group Ltd., Thermo Fisher Scientific Company, Cell Culture Company, LLC, Sartorius AG, Becton, Dickinson and Company, Hamilton Company, Merck Group, F. Hoffmann-La Roche AG, Novartis AG
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample